Age-Adjusted Serum Neurofilament Predicts Cognitive Decline in Parkinson's Disease (MARK-PD). Buhmann C, Lezius S, Potter-Nerger M, Gerloff C, et al. Mov Disord 2022 Jan 17. doi: 10.1002/mds.28909.

Read + Share

Amedeo Smart

Independent Medical Education

Buhmann C, Lezius S, Potter-Nerger M, Gerloff C, et al. Age-Adjusted Serum Neurofilament Predicts Cognitive Decline in Parkinson's Disease (MARK-PD). Mov Disord 2022 Jan 17. doi: 10.1002/mds.28909.
PMID: 35040209